olsalazine

Known as: 3,3'-Dicarboxy-4,4'-dihydroxyazobenzene, 3,3'-Azobis[6-hydroxybenzoic Acid], olsalazine [Chemical/Ingredient]

A prodrug of mesalamine (5-Aminosalicylic acid; 5-ASA) with anti-inflammatory activity. Unabsorbed olsalazine passes through gastrointestinal tract…

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2017

The reagent 6-(5-chloro-2-hydroxy-3-sulfophenylazo)-5-hydroxy-1-naphthalene sulfonic acid (Mordant blue – 9) is proposed as a…

2005

Frequent minor side effects are associated with sulfasalazine. The realization that it is the 5-aminosalicylic acid moiety that…

2003

A randomized controlled trial of a humanized Alpha 4 Beta 7 antibody in Ulcerative Colitis (UC)

1997

A 73 year-old woman with ulcerative colitis developed skin rashes after long-standing sulphasalazine treatment. After a switch to…

1996

UNLABELLED Aminosalicylates are used to maintain remission in patients with ulcerative colitis. Since there are potential…

1993

Objective: To report a case where a patient receiving olsalazine for control of ulcerative colitis developed high fever with…

1988

Pharmacokinetic aspects of drugs targeted for the colon, with special reference to olsalazine

1988

1987

Olsalazine (ADS) is the azo-linked dimer of 5-aminosalicylic acid (5-ASA). It is of value for the management of patients with…

1979

Ruth Prawer Jhabvala, whose Polish roots have penetrated deeply into the Indian soil during the twenty-four years that she has…